Effect of pindolol on serum lipids and lipid metabolizing enzymes
- PMID: 7104159
- PMCID: PMC1402150
- DOI: 10.1111/j.1365-2125.1982.tb01955.x
Effect of pindolol on serum lipids and lipid metabolizing enzymes
Abstract
1 The effect on plasma lipids of pindolol given orally over a 6 month period to 20 patients with essential hypertension was studied. 2 During therapy an adipose tissue biopsy was taken from nine patients for the determination of lipoprotein lipase (LPL) activity and serum samples were taken for lecithin cholesterol acyltransferase (LCAT) assays. An additional biopsy and serum samples were taken after a 3 weeks' break in pindolol treatment. 3 Plasma free fatty acid and triglyceride concentrations remained similar during treatment. 4 Plasma total cholesterol was slightly lower (P less than 0.05) at 6 months than at 1 month. 5 HDL cholesterol concentration and the ratio of HDL to total cholesterol increased slightly, and the increase of HDL-cholesterol was significant (P less than 0.05) at 1 month. 6 LCAT activity was significantly higher (P less than 0.01) during pindolol treatment than after the break in it. No significant changes in adipose tissue LPL activities were found before and after the break of treatment.
Similar articles
-
Effects of high dose progestin on serum lipids and lipid metabolizing enzymes in patients with endometrial cancer.Horm Metab Res. 1985 Jan;17(1):32-4. doi: 10.1055/s-2007-1013440. Horm Metab Res. 1985. PMID: 3155702
-
Effects of beta-blockers on plasma lipids during antihypertensive therapy.J Cardiovasc Pharmacol. 1985;7 Suppl 2:S110-4. doi: 10.1097/00005344-198507002-00021. J Cardiovasc Pharmacol. 1985. PMID: 2409357 Review.
-
Lipid transport in the hypothyroid rat as reflected by the serum concentrations of free fatty acids, lipoproteins, lecithin-cholesterol acyltransferase and lipoprotein lipase activity in adipose tissue.J Endocrinol Invest. 1981 Jan-Mar;4(1):75-80. doi: 10.1007/BF03349419. J Endocrinol Invest. 1981. PMID: 7240672
-
Protective effect of rutin on lipids, lipoproteins, lipid metabolizing enzymes and glycoproteins in streptozotocin-induced diabetic rats.J Pharm Pharmacol. 2006 Oct;58(10):1373-83. doi: 10.1211/jpp.58.10.0011. J Pharm Pharmacol. 2006. PMID: 17034661
-
The relevance of plasma lipid changes with cardiovascular drug therapy.Med Clin North Am. 1989 Mar;73(2):449-73. doi: 10.1016/s0025-7125(16)30682-4. Med Clin North Am. 1989. PMID: 2645483 Review.
Cited by
-
Effect of oxprenolol and metoprolol on serum lipid concentration.Eur J Clin Pharmacol. 1984;26(3):331-4. doi: 10.1007/BF00548763. Eur J Clin Pharmacol. 1984. PMID: 6734694 Clinical Trial.
-
Beta-blocker induced changes in the cholesterol: high-density lipoprotein cholesterol ratio and risk of coronary heart disease.Klin Wochenschr. 1984 Sep 17;62(18):843-9. doi: 10.1007/BF01711998. Klin Wochenschr. 1984. PMID: 6149331
-
[Antihypertensive therapy and lipid metabolism].Klin Wochenschr. 1984 Mar 1;62(5):193-202. doi: 10.1007/BF01721044. Klin Wochenschr. 1984. PMID: 6143851 Review. German.
-
Thiazides, beta blockers and lipoproteins.Postgrad Med J. 1983 Aug;59(694):483-8. doi: 10.1136/pgmj.59.694.483. Postgrad Med J. 1983. PMID: 6137813 Free PMC article. Review.
-
Pindolol--a beta-adrenoceptor blocking drug with partial agonist activity: clinical pharmacological considerations.Br J Clin Pharmacol. 1982;13(Suppl 2):187S-192S. doi: 10.1111/j.1365-2125.1982.tb01909.x. Br J Clin Pharmacol. 1982. PMID: 6125169 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous